Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 286817, 8 pages
Research Article

Determination of the In Vitro and In Vivo Antimicrobial Activity on Salivary Streptococci and Lactobacilli and Chemical Characterisation of the Phenolic Content of a Plantago lanceolata Infusion

1Department of Neurosciences, Reproduction and Odontostomatologic Sciences, University of Naples “Federico II”, Via Pansini 5, 80100 Naples, Italy
2Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80100 Naples, Italy
3Department of Chemical Sciences, University of Naples “Federico II”, Via Pansini 5, 80100 Naples, Italy
4Department of Biology, University of Naples “Federico II”, Via Pansini 5, 80100 Naples, Italy

Received 17 September 2014; Revised 28 January 2015; Accepted 29 January 2015

Academic Editor: Paul M. Tulkens

Copyright © 2015 Gianmaria Fabrizio Ferrazzano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. Plant extracts may be suitable alternative treatments for caries. Aims. To investigate the in vitro and in vivo antimicrobial effects of Plantago lanceolata herbal tea (from flowers and leaves) on cariogenic bacteria and to identify the major constituents of P. lanceolata plant. Materials and Methods. The MIC and MBC against cariogenic bacteria were determined for P. lanceolata tea. Subsequently, a controlled random clinical study was conducted. Group A was instructed to rinse with a P. lanceolata mouth rinse, and Group B received a placebo mouth rinse for seven days. The salivary colonisation by streptococci and lactobacilli was investigated prior to treatment and on the fourth and seventh days. Finally, the P. lanceolata tea was analysed for its polyphenolic content, and major phenolics were identified. Results and Discussion. P. lanceolata teas demonstrate good in vitro antimicrobial activity. The in vivo test showed that Group A subjects presented a significant decrease in streptococci compared to Group B. The phytochemical analysis revealed that flavonoids, coumarins, lipids, cinnamic acids, lignans, and phenolic compounds are present in P. lanceolata infusions. Conclusions. P. lanceolata extract could represent a natural anticariogenic agent via an antimicrobial effect and might be useful as an ancillary measure to control the proliferation of cariogenic flora.

1. Introduction

Although the prevalence of dental caries has been slowly declining in many developed countries, this disease continues to be a major public health problem in industrialised countries and has become an emerging public health problem in developing countries [1].

Various preventive measures have been attempted to control the insurgence of dental caries, such as topical or systemic fluorides, fissure sealants, and dietary approaches, but they are not sufficient to control the disease, which has a multifactorial aetiology [2].

Bacteria belonging to different species of Streptococcus and Lactobacillus play a lead role in the development and progression of caries [3]. Because these microorganisms are the most prominent factors in dental caries process, reducing their level in the oral cavity will provide an additional rationale for the prevention of dental caries [4].

Chlorhexidine is an antimicrobial agent clinically efficient against a wide range of cariogenic microorganisms [5]. However, the use of chlorhexidine for caries prevention has been a controversial topic among dental educators and clinicians, due to several undesirable side effects, including the formation of extrinsic stain on the tooth and tongue and emergence of bacterial resistance [6]. Within this context, alternative antimicrobial treatments, such as antibacterial compounds extracts from plants, reducing cariogenic microflora salivary counts, can be proposed to control this disease [710].

The genus Plantago (Plantaginaceae) encompasses approximately 275 species with a cosmopolitan distribution. Recent studies have confirmed that some Plantago species have considerable antiviral, anti-inflammatory, and antioxidant activities [1113]. Phytochemical studies have also shown that the genus Plantago contains a great amount of phenolic compounds (flavonoids and tannins). In particular, phenolic compounds seem to play a potential role in the control of bacterial growth and could prevent tooth decay, decreasing growth, and virulence of pathogenic oral flora [14]. A recent study has reported that P. lanceolata methanol/water extracts are rich in phenolic acids, with the benzoic acid derivatives hydroxybenzoate and 3,4,5-trihydroxybenzoate (gallic acid) being the most highly represented [11].

Hot infusions (herbal teas) represent by far the most popular type of consumption of herb to which medicinal properties have been acknowledged in traditional medicine [15]. Tsai et al. (2008) have demonstrated that several herbs commonly used as tea in Taiwan exhibited anticariogenic and anti-inflammatory properties [16]. According to European Medicines Agency (EMA) [17], herbal tea made from P. lanceolata leaves is used in European countries as a demulcent for the local treatment of oral or pharyngeal irritations and is considered a safe preparation with no known contraindications. In this study, an in vitro assessment of the antimicrobial activity of P. lanceolata tea against cariogenic bacterial strains of the species Streptococcus and Lactobacillus isolated from clinical samples was performed; subsequently, a mouth rinse made with an infusion of dried P. lanceolata leaves and flowers was tested in vivo for its effectiveness in reducing cariogenic microflora salivary counts. Finally, the P. lanceolata herbal tea was analysed for its polyphenolic content, and major phenolics were identified.

2. Materials and Methods

2.1. Chemicals and Reagents

Phenolic compound standards were purchased from Sigma Aldrich (Milan, Italy). All the other chemicals and solvents were purchased from Fluka (Saint-Quentin Fallavier, France) at analytical or HPLC grade and were used as received.

2.2. Plant Material and Extract Preparation

P. lanceolata was collected in June 2012 in the Royal Park of Capodimonte, Naples, Italy. The voucher specimen (no. 0134) was prepared and identified in our lab and deposited at the Herbarium of the Botanical Garden of the “Federico II” University in Naples, Italy.

Flowers, leaves, and roots of P. lanceolata were dried separately at 55°C for 48 h in a Carlo ErbaE.28 CL.1 Oven and then ground to a coarse powder. A total of 2 g of powder of each part of the plant was suspended in 20 mL of Amorosa water (still mineral water, low in sodium, and ideal for the preparation of baby and toddler food) at 100°C for 3 min. The preparation was infused for 8 min and then was cooled to room temperature, filtered, and evaporated to complete dryness.

To prepare the mouth rinse, 200 g of pulverised material (flowers and leaves) was suspended in 2.0 L of Amorosa water following the same procedure previously described. The preparation was filtered, placed in a sterilised 3.0 L glass container, and stored at 4°C before use.

2.3. In Vitro Antimicrobial Tests

The bacterial strains used for testing were L. casei, S. bovis, S. mutans, S. mitis, S. parasanguinis, S. viridans, and S. sobrinus. The strains were from clinical specimens obtained at the Diagnostic Unit of Bacteriology and Micology of the University of Naples “Federico II.” Bacteria were grown on Trypticase Soy Agar with 5% Sheep Blood (TSS; Becton Dickinson, USA) plates at 37°C in 5% CO2 for 48 h.

The minimum inhibitory concentration (MIC) was measured using the standard microdilution method in 96-well polystyrene plates using brain-heart infusion (BHI) medium. The starting inoculum was 5 × 105 CFU mL−1, and the final concentrations of the P. lanceolata infusion ranged from 4 to 0.025 mg mL−1. To determine the minimal bactericidal concentration (MBC), 50 μL of bacterial suspension from the wells containing extract concentrations equal to or higher than the MIC were inoculated in 5 mL of sterile BHI medium and incubated for 24 h at 37°C under a 5% CO2 atmosphere.

2.4. Biologic Assays on Human-Lymphocytic Cells

We have chosen two human cell lines one p53 negative and one p53 positive.

The p53-null U937 human leukemic monocyte lymphoma and the p53-positive isogenic human lymphoblast TK6 cell lines were obtained from American Type Culture Collection (Rockville, MD). Both cells lines grew in Dulbecco’s Modified Eagle Medium, 2 mM l-glutamine, 100 μg/mL streptomycin, 100 units/mL penicillin, and 10% foetal calf serum (FCS). All media and cell culture reagents were purchased from Life Technologies (San Giuliano Milanese, Italy).

Cell viability was assayed by using the Cell Proliferation Kit II (XTT, Roche, Milan, Italy). This assay is based on the cleavage of the yellow tetrazolium salt XTT to form an orange formazan dye by metabolic active cells; therefore, this conversion only occurs in viable cells.

The plant extracts were provided to our laboratory in the relative extraction solvents having all a nominal concentration of 50 mg/mL. The extracts were dried under vacuum and redissolved in DMSO 10% in water. Samples were stored at −30°C until use. Before measurements, samples were brought to room temperature under agitation and added to culture media in a ratio 1 to 10. In detail, 90 μL of suspensions of U937 or TK6 cells (containing ~1 × 104 cells in complete medium) were seeded into 96-well plates. Then, 10 μL of each extract (50 mg/mL in 10% DMSO) was added to each well so that the final extract concentration was 5 mg/mL, while the DMSO content was reduced to 1%. Cells were incubated in these conditions at 37°C for 24 h in 5% CO2 atmosphere. Triplicate samples were prepared for any individual condition. As a positive control for cytotoxicity we used Triclosan at low concentration (0.03% as compared with 3% used in toothpastes). This synthetic is a polychloro-phenoxy phenol endowed with antibacterial and antifungal properties. For these reasons it is currently largely used in oral hygiene as additive of toothpastes to prevent gingivitis.

2.5. In Vivo (Clinical) Antimicrobial Tests

The clinical studywas conducted on a sample consisting of forty-four adolescents (24 males and 20 females) enrolled in the Department of Paediatric Dentistry at the University of Naples “Federico II”, Italy, ranging from 12 to 18 years old.

The inclusion criteria were good general health (ASA I: Healthy person; ASA II: Mild systemic disease) and an agreement to comply with study procedures.

Subjects who had used antibiotics or mouth rinses during the 14 days prior to the beginning of the study were excluded.

Only 2 subjects of the 44 were excluded for this reason. However, during the research period, 2 subjects chose to end their participation; thus, 40 subjects completed the entire protocol. Participation in the study was voluntary. All of the parents gave written informed consent after receiving verbal and written explanations of the experimental protocol and study aims. The protocol was approved by the Ethical Committee of the School of Dentistry, University of Naples “Federico II”, Italy.

A controlled random clinical study was conducted. The subjects were divided into 2 groups of 20 subjects, respectively (Group A and Group B). Patients were randomly assigned to test and control groups using blocked randomisation from a computer-generated list.

Salivary counts of S. mutans and L. casei were estimated using a chair-side test that contained 2 agar surfaces. The blue mitis-salivarius-agar with bacitracin was used to detect the presence of streptococci, whereas the light culture medium, Rogosa agar, was used to evaluate that of lactobacilli.

No special dietary restrictions were imposed on the subjects, and no tooth brushing was allowed for at least 1 h after consuming lunch and dinner. All of the subjects were encouraged to maintain their normal oral hygiene habits. All subjects were given the same brush and tooth-paste for daily oral hygiene.

Saliva was inoculated on a dip slide with selective media for streptococci and lactobacilli. After adding a NaHCO3 tablet to the tube, the dip slides were immediately cultivated at 37°C for 48 h. The tablet releases CO2 on contact with moisture, creating favourable conditions for bacterial growth.

The colonies were identified using a stereomicroscope with ×10 magnification, and the culture density (CFU/mL) was visually compared with the aid of a chart provided by the manufacturer. Bacterial colonies were categorised as low (<105 CFU/mL of saliva) or high (> or = 105 CFU/mL).

Two different mouth rinse formulations were prepared.

(1) Experimental mouth rinse (Group A): an experimental mouth rinse was prepared with an infusion of P. lanceolata leaves and flowers, as previously described.

(2) Placebo mouth rinse (Group B): the placebo mouth rinse was prepared with Amorosa water, coloured with food dye.

Experimental Design. During the experimental period, after collecting the first saliva sample (T0), all of the Group A participants were asked to rinse with 10 mL of the experimental mouth rinse; instead, the participants of Group B were instructed to rinse with 10 mL of a placebo mouth rinse that did not contain phenolic substances, for 60 seconds after performing oral hygiene, 3 times a day (after breakfast, after lunch, and before sleeping) for 7 days.

On the 4th (T1) and 7th (T2) days of treatment, additional salivary samples were collected and immediately incubated to calculate the density (CFU/mL) of S. mutans and L. casei for each subject.

Statistical Analysis. At the end of the treatments, the data were processed using the Statistical Package for Social Sciences (version 10.0, SPSS Inc., Chicago, Illinois, USA). A regression binary logistic analysis was performed. The statistical significance level was established at .

2.6. Analysis of Phenolics

Infusions of P. lanceolata whole plants and separated parts (flowers, leaves, and roots) were subjected to different chemical tests to detect the presence of flavonoids [18], coumarins [19], lipids and cinnamic acids [20], and tannins [21].

Column chromatography (CC) was performed on a Merck Kieselgel 60 (230–400 mesh). HPLC was performed on a Shimadzu LC-10AD using a Shimadzu RID-10A UV-VIS detector. A semipreparative HPLC was performed using an RP18 (LiChrospher 10 μm, 250 × 10 mm i.d., Merck) column with a flow rate of 1.2 mL min−1, using an injection volume of 200 μL and a binary mixture of water/formic acid 0.1% (99 : 1) and methanol (solvents A and B, resp.). The gradient was as follows: 0 min, 70% A/30% B, reaching 35% A/65% B after 12 min, then reaching 100% B after 25 min, which was maintained for 12 min. A 10 min equilibration time was used between analyses.

1H- and 13C-NMR spectra were recorded on a Varian INOVA-500 NMR instrument (1H at 499.6 MHz and 13C at 125.62 MHz), referenced with deuterated solvents (CDCl3 or CD3OD) at 25°C. Proton-detected heteronuclear correlations were measured using a gradient heteronuclear single-quantum coherence (HSQC), optimised for = 155 Hz, and a gradient heteronuclear multiple bond coherence (HMBC), optimised for = 8 Hz.

MS spectra were obtained using a HP 6890 spectrometer equipped with an MS 5973 N detector. HR-ESI-MS/MS was performed using a Q-TRAP model API-2000 LC-MS/MS system equipped with a heated nebuliser source and using the Analyst software (Applied Biosystems).

2.7. Determination of Total Phenolic Content

Total phenolic content was determined spectrophotometrically according to the Folin-Ciocalteu’s method with slight modifications [22]. Briefly, 1.0 mL of properly diluted samples, calibration solutions, or blank solution were pipetted into separate test tubes (20 mL) and 1.0 mL of Folin-Ciocalteu’s reagent was added to each. The mixture was mixed well and allowed to equilibrate. After exactly 10 min, 10 mL of milliQ water and 3.0 mL of Na2CO3 solution (w = 5%) were added and the volume was made up with milliQ water. The mixture was swirled and put in a water bath at 40°C for 20 min. Then, the tubes were rapidly cooled on ice, and the colour generated was read at its maximum absorption. The measurements were compared to a standard curve of prepared gallic acid solutions (50, 100, 150, 250, and 500 mg L−1) and expressed as milligrams of gallic acid equivalents. All measurements were performed in triplicate, the absorbance was measured in 1 cm cuvettes, and for calibration solutions and blank preparation, a methanolic solution at the same concentration as the samples was used.

3. Results

3.1. Determination of P. lanceolata Infusion Phenolic Content and Identification of Major Constituents

A preliminary analysis was performed to identify the major constituents of the whole P. lanceolata plant. Flavonoids, coumarins, lipids, cinnamic acids, lignans, and phenolic compounds are present in infusions of P. lanceolata (Table 1).

Table 1: Average amount of the main classes of compounds in the infusion of the whole P. lanceolata plant.

The hot water infusion of the entire P. lanceolata (flowers, leaves, and roots) contains different classes of phenolics, including flavonoids, coumarins, lipids, and cinnamic acids at a range of concentrations (Table 2). In the lyophilised infusion, the level of phenolic compounds was  mg GA equiv/g DW, as revealed by HPLC analysis. The level of total phenolics, as detected by Folin-Ciocalteu’s method, was higher ( mg GA equiv/g DW); the difference can be explained by the presence of protein, ascorbic acid, or reducing sugars in P. lanceolata, which contribute to higher Folin-Ciocalteu values. An LC/MS/MS technique was applied to the hot infusion prepared from P. lanceolata leaves (yield of 5.4% of the air-dried raw material mass), leading to the isolation of several polyphenols, including flavonoids, of which the most abundant were apigenin (14), luteolin (15), and luteolin-7-O-glucoside (16). Quercetin-3-rutinoside (rutin, 2), quercetin-3-O-D-galactopyranoside (hyperoside, 3), 3,5,7,4-tetrahydroxyflavonol (kaempferol, 4), 3,5,7,3,4-pentahydroxyflavone (quercetin, 5), and 3,5,3,4-tetrahydroxy-7-methoxyflavonol (rhamnetin, 6) were also present, while naringenin (17) was present only in trace amounts, in agreement with the data that Beara et al. (2012) reported for methanol extracts (Figure 1) [11]. Other phenolic compounds with lower molecular weights were identified as vanillic (10) and gallic (1) acids, and three derivatives of the latter: 3-O-galloyl-4,6-hexahydroxydiphenoyl-D-glucose (7), 2,3-di-O-galloyl-D-glucose (8), and 1,2,3-tri-O-galloyl-D-glucose (9), which was the most abundant [23]. Furthermore, a significant amount of cinnamic acids including cinnamic (11), caffeic (12) [11], and chlorogenic (13) acids was measured (Figure 2).

Table 2: Results of the phytochemical analysis of the infusion of flowers, leaves, and roots of P. lanceolata.
Figure 1: General structures of flavonoids isolated from P. lanceolata.
Figure 2: Cinnamic derivatives of P. lanceolata.
3.2. In Vitro Antimicrobial and Biological Assays

An infusion of dried flowers and leaves was used to assess the in vitro antimicrobial activity of P. lanceolata, expressed in terms of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) (Table 3). Strains belonging to several species of Streptococcus, namely, S. bovis, S. mitis, S. sobrinus, S. mutans, S. parasanguinis, and S. viridans and one strain of L. casei, that were isolated from clinical specimens were selected for the bioassay. The infused P. lanceolata was assayed at concentrations ranging from 4 to 0.025 mg/mL. The susceptibility of the strains to the tea varied considerably; however, concentrations between 250 μg/mL and 2.0 mg/mL showed antimicrobial activity, affecting the viability of all bacteria tested. As far as it concerns the effects on human cell lines of P. lanceolata infusion, we have found that the viability of both cell lines used, namely TK6 and U937 incubated in the presence of extract concentrations up to 4 mg/mL does not decrease in comparison with the respective controls.

Table 3: In vitro antimicrobial activity of P. lanceolata, expressed in terms of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC).
3.3. In Vivo Assessment of Antimicrobial Activity of P. lanceolata Infusions

For the test group the differences in streptococci concentration (CFU/mL) between T0 and T1 and between T0 and T2 were significant ( for both); the difference between T1 and T2 was not significant. The differences in lactobacilli concentration (CFU/mL) were not significant between any two time points.

For the control group the differences in the density (CFU/mL) of streptococci and lactobacilli were not significant.

The difference in the streptococci density between test and control groups was not significant at T0 but was significant at T1 and T2, whereas the differences in the lactobacilli concentration were not significant (Table 4).

Table 4: Density of the Streptococci mutans CFU (> or = 105 CFU/mL) and Lactobacilli casei CFU (> or = 105 CFU/mL) at T0, T1, and T2.

4. Discussion

P. lanceolata infusions demonstrated good in vitro antimicrobial activity, particularly against streptococci. The biocide potential of some species of the genus Plantago is well known: P. major extracts, for example, caused strong alterations in the cell wall structure of different gram positive bacteria [24]. Also P. lanceolata extracts in different solvents exhibited mild antimicrobial activity, most likely due to the presence of flavonoids and terpenes [25]. Interestingly, the water extracts of P. lanceolata produced the best antimicrobial effects, exhibiting weak or moderate antimicrobial activity against S. aureus, S. epidermidis, S. marcescens, and Proteus vulgaris [26]. Moreover, Bazzaz and Haririzadeh (2003) reported that the pressed juice of fresh P. lanceolata has a bactericidal effect [27].

The clinical test demonstrated that subjects who used a P. lanceolata mouth rinse presented a significant decrease in streptococci compared to subjects treated with the placebo, whereas only a slight (not significant) decrease was observed for lactobacilli counts following the treatment.

Apart from the strain-specific differences, a possible explanation for the poor reduction of lactobacilli with respect to streptococci is that the latter normally grows on exposed surfaces that are easily accessible, whereas lactobacilli and related species recover in shed retentive areas [28] that have limited contact with the mouth rinse.

Furthermore, in the present study, only the short-term (seven days) effect of P. lanceolata against oral streptococci and lactobacilli was assessed in vivo. The promising results we have got suggest that further studies need to be undertaken to establish whether the capability of reducing mutans streptococci salivary counts will be long lasting, and whether no resistance will occur. In addition, the long-term patient acceptability and compliance need to be assessed.

The phenolic content and the major phenolic compounds of the whole plant infusion, as well as that of isolated leaves, flowers, and roots of P. lanceolata, were determined. The results of analysis showed that all extracts have a high phenolic content. Nine flavonoids, three cinnamic acids, two compounds with a C6-C1 skeleton, and three of their glycosylated derivatives were identified. In particular, the leaf extract is the richest in polyphenols, followed by that of the flowers and, to a lesser extent, the roots. A significant difference in the flavonoid content was also detected, with the highest flavonoid content occurring in the flower extract, followed by the leaves, whereas none was detected in the roots. In accordance with previous studies on P. lanceolata phenolic constituents [11], our analyses also detected the presence of cinnamic acids in all extracts, but most prevalently in the leaves. The content of coumarins was lower than the other phenolics, however, and constant in the three types of extracts. In contrast, the lipid content was markedly low and only present in the root extract. Finally, no lignans were found in any of the extracts that were analysed. The antistreptococcal activity of P. lanceolata infusions could be related to the phenolic substances occurring in the infusion and is most likely the result of the synergistic activity of the many phenolics that were isolated. Chlorogenic and caffeic acids inhibit the growth of S. mutans [29], and the presence of significant concentrations of apigenin, an effective inhibitor of GTFs from S. mutans and S. sanguinis, is also noteworthy. The adherence of bacterial cells to the tooth surface is important for the development of carious lesions, and interference with the mechanisms of adherence can prevent dental caries. Furthermore, as suggested by Özan et al., the phenolic substances found in plant extracts most likely act on the microbial membrane or the surface of the cell wall, causing structural and functional damage [30]. However, further research is needed to identify which pure compound could be responsible for the antibacterial properties and to determine its potential for use in pharmaceutical industries.

P. lanceolata mouth rinse might offer a new option for the microbiological control of dental caries because the infusion is easily obtained and inexpensive and exhibits beneficial effects. There is an urgent need for alternative prevention and treatment options that are safe, effective, and economical, given the incidence of oral disease and the adverse effects (as tooth and tongue discoloration and taste disorder) of certain antibacterial agents that are currently used in dentistry.

Based on these considerations, a P. lanceolata infusion might be useful as an ancillary measure to control the proliferation of oral cariogenic flora. Further studies, particularly in vivo and in situ studies, are needed to establish conclusive evidence of the effectiveness of P. lanceolata extract against dental caries, either alone or in combination with conventional therapies, for improving oral health.

Conflict of Interests

The authors declare that there is no conflict of interests.


  1. G. Campus, S. G. Condò, G. di Renzo et al., “National Italian Guidelines for caries prevention in 0 to 12 years-old children,” European Journal of Paediatric Dentistry, vol. 8, no. 3, pp. 153–159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. D. Marsh, “Are dental diseases examples of ecological catastrophes?” Microbiology, vol. 149, no. 2, pp. 279–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Seminario, Z. Broukal, and R. Ivancaková, “Mutans streptococci and the development of dental plaque,” Prague Medical Report, vol. 106, no. 4, pp. 349–358, 2005. View at Google Scholar · View at Scopus
  4. S. K. Pallavi, “Effect of chlorhexidine on Mutans Streptococci and dental caries,” Journal of Indian Association of Public Health Dentistry, no. 17, pp. 678–683, 2011. View at Google Scholar
  5. S. Matthijs and P. A. Adriaens, “Chlorhexidine varnishes: a review,” Journal of Clinical Periodontology, vol. 29, no. 1, pp. 1–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Autio-Gold, “The role of chlorhexidine in caries prevention,” Operative Dentistry, vol. 33, no. 6, pp. 710–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. Palombo, “Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 680354, 15 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. F. Ferrazzano, I. Amato, A. Ingenito, A. Zarrelli, G. Pinto, and A. Pollio, “Plant polyphenols and their anti-cariogenic properties: a review,” Molecules, vol. 16, no. 2, pp. 1486–1507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. F. Ferrazzano, L. Roberto, M. R. Catania et al., “Screening and scoring of antimicrobial and biological activities of italian vulnerary plants against major oral pathogenic bacteria,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 316280, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. G. F. Ferrazzano, L. Roberto, I. Amato, T. Cantile, G. Sangianantoni, and A. Ingenito, “Antimicrobial properties of green tea extract against cariogenic microflora: an in vivo study,” Journal of Medicinal Food, vol. 14, no. 9, pp. 907–911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. I. N. Beara, M. M. Lesjak, D. Z. Orčić et al., “Comparative analysis of phenolic profile, antioxidant, anti-inflammatory and cytotoxic activity of two closely-related Plantain species: Plantago altissima L. and Plantago lanceolata L.,” LWT—Food Science and Technology, vol. 47, no. 1, pp. 64–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Gálvez, C. Martín-Cordero, P. J. Houghton, and M. J. Ayuso, “Antioxidant activity of Plantago bellardii All,” Phytotherapy Research, vol. 19, no. 12, pp. 1074–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Gálvez, C. Martín-Cordero, P. J. Houghton, and M. J. Ayuso, “Antioxidant activity of methanol extracts obtained from Plantago species,” Journal of Agricultural and Food Chemistry, vol. 53, no. 6, pp. 1927–1933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Smullen, G. A. Koutsou, H. A. Foster, A. Zumbé, and D. M. Storey, “The antibacterial activity of plant extracts containing polyphenols against Streptococcus mutans,” Caries Research, vol. 41, no. 5, pp. 342–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Evans, “Chile stories: exploring herbal medicine in South America,” Australian of Journal Medical Herbalism, vol. 14, no. 1, pp. 2–6, 2002. View at Google Scholar
  16. T.-H. Tsai, Y.-C. Chien, C.-W. Lee, and P.-J. Tsai, “In vitro antimicrobial activities against cariogenic streptococci and their antioxidant capacities: a comparative study of green tea versus different herbs,” Food Chemistry, vol. 110, no. 4, pp. 859–864, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Committee on Herbal Medicinal Products (HMPC), “Community herbal monograph on Plantago lanceolata L., folium,” Tech. Rep. EMA/HMPC/437858/2010, 2011. View at Google Scholar
  18. C.-C. Chang, M.-H. Yang, H.-M. Wen, and J.-C. Chern, “Estimation of total flavonoid content in propolis by two complementary colometric methods,” Journal of Food and Drug Analysis, vol. 10, no. 3, pp. 178–182, 2002. View at Google Scholar · View at Scopus
  19. A. M. Khan, R. A. Qureshi, F. Ullah et al., “Phytochemical analysis of selected medicinal plants of Margalla hills and surroundings,” Journal of Medicinal Plant Research, vol. 5, no. 25, pp. 6017–6023, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Khoddami, M. A. Wilkes, and T. H. Roberts, “Techniques for analysis of plant phenolic compounds,” Molecules, vol. 18, no. 2, pp. 2328–2375, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Sembratowicz, K. Ognik, E. Rusinek, and J. Truchlinski, “Contents of tannins and oxalic acid in selected medicinal plants harvested in two vegetation periods,” Bromatologia i Chemia Toksykologiczna, vol. 39, no. 3, pp. 277–280, 2006. View at Google Scholar
  22. N. Cicco, M. T. Lanorte, M. Paraggio, M. Viggiano, and V. Lattanzio, “A reproducible, rapid and inexpensive Folin-Ciocalteu micro-method in determining phenolics of plant methanol extracts,” Microchemical Journal, vol. 91, no. 1, pp. 107–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. R. Makhmudov, N. G. Abdulladzhanova, and F. G. Kamaev, “Phenolic compounds from Plantago major and P. lanceolata,” Chemistry of Natural Compounds, vol. 47, no. 2, pp. 288–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. A. Sharifa, Y. L. Neoh, M. I. Iswadi et al., “Effects of methanol, ethanol and aqueous extract of Plantago major on gram positive bacteria, gram negative bacteria and yeast,” Annals of Microscopy, vol. 8, pp. 42–44, 2008. View at Google Scholar
  25. A. Nostro, M. P. Germanò, V. D'Angelo, A. Marino, and M. A. Cannatelli, “Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity,” Letters in Applied Microbiology, vol. 30, no. 5, pp. 379–384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Pehlivan Karakaş, A. Yildirim, and A. Türker, “Biological screening of various medicinal plant extracts for antibacterial and antitumor activities,” Turkish Journal of Biology, vol. 36, no. 6, pp. 641–652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. S. F. Bazzaz and G. Haririzadeh, “Screening of Iranian plants for antimicrobial activity,” Pharmaceutical Biology, vol. 41, no. 8, pp. 573–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. S. K. Cildir, D. Germec, N. Sandalli et al., “Reduction of salivary mutans streptococci in orthodontic patients during daily consumption of yoghurt containing probiotic bacteria,” European Journal of Orthodontics, vol. 31, no. 4, pp. 407–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. P. Almeida, A. Farah, D. A. M. Silva, E. A. Nunan, and M. B. A. Glória, “Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria,” Journal of Agricultural and Food Chemistry, vol. 54, no. 23, pp. 8738–8743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Özan, Z. Sümer, Z. A. Polat, K. Er, U. Ozan, and O. Deger, “Effect of mouthrinse containing propolis on oral microorganisms and human gingival fibroblasts,” European Journal of Dentistry, vol. 1, no. 4, pp. 195–201, 2007. View at Google Scholar